CARDIOVASCULAR MEDICINE

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I

J C Moon¹, J Mogensen², P M Elliott², G C Smith¹, A G Elkington¹, S K Prasad¹, D J Pennell¹, W J McKenna²

¹ Centre for Advanced Magnetic Resonance in Cardiology (CAMRIC), Royal Brompton Hospital, London, UK
² Cardiology in the Young, The Heart Hospital, University College London Hospitals Trust, London, UK

Correspondence to:
Correspondence to:
Professor William J McKenna
Cardiology in the Young, The Heart Hospital, University College London Hospitals Trust, 16–18 Westmoreland Street, London W1G 8PH, UK; william.mckenna{at}uclh.org

Objective: To examine the influence of genotype on late gadolinium enhancement (LGE) and the potential of cardiovascular magnetic resonance (CMR) to detect preclinical hypertrophic cardiomyopathy.

Design: Prospective, blinded cohort study of myocardial LGE in a genetically homogeneous population.

Patients: 30 patients with disease causing mutations in the recognised hypertrophic cardiomyopathy gene for cardiac troponin I (TNNI3): 15 with echocardiographically determined left ventricular hypertrophy (LVH+) and 15 without (LVH–).

Main outcome measures: CMR measures of regional left ventricular function, wall thickness, and mass, and the extent and distribution of LGE.

Results: LGE was found in 12 (80%) LVH+ patients but with variable extent (mean 15%, range 3–48%). LGE was also found in two (13%) LVH– patients but the extent was limited (3.6%) and both patients were found to have an abnormal ECG and regional hypertrophy by cine CMR. The extent of LGE was positively associated with clinical markers of sudden death risk (21% with 2 risk factors v 7% with 1 risk factor, p = 0.02) and left ventricular mass (r = 0.56, p < 0.001) and was inversely associated with ejection fraction (r = –0.58, p < 0.001). Segmental analysis showed that as regional wall thickness increased, LGE was more prevalent (p < 0.0001) and more extensive (r = 0.98, p = 0.001).

Conclusion: In patients with disease causing mutations in TNNI3, focal fibrosis was not detected by LGE CMR before LVH and ECG abnormalities were present. Once LVH is present, LGE is common and the extent correlates with adverse clinical parameters. This suggests that focal fibrosis is closely linked to disease development.

Abbreviations: CMR, cardiovascular magnetic resonance; DTPA, diethylenetriaminepentaacetic acid; HCM, hypertrophic cardiomyopathy; LGE, late gadolinium enhancement; LVH, left ventricular hypertrophy

Keywords: hypertrophic cardiomyopathy; magnetic resonance imaging; fibrosis; gadolinium

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Leonardi, S., Raineri, C., De Ferrari, G. M., Ghio, S., Scelsi, L., Pasotti, M., Tagliani, M., Valentini, A., Dore, R., Raisaro, A., Arbustini, E. (2009). Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy. Eur Heart J 30: 2003-2010 [Abstract] [Full Text]  
• Kwon, D. H., Smedira, N. G., Rodriguez, E. R., Tan, C., Setser, R., Thamilarasan, M., Lytle, B. W., Lever, H. M., Desai, M. Y. (2009). Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia.. J Am Coll Cardiol 54: 242-249 [Abstract] [Full Text]  
• Rudolph, A., Abdel-Aty, H., Bohl, S., Boye, P., Zagrosek, A., Dietz, R., Schulz-Menger, J. (2009). Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.. J Am Coll Cardiol 53: 284-291 [Abstract] [Full Text]  
• Bandettini, W P, Arai, A E (2008). Advances in clinical applications of cardiovascular magnetic resonance imaging. Heart 94: 1485-1495 [Abstract] [Full Text]  
• Olivotto, I., Maron, M. S., Autore, C., Lesser, J. R., Rega, L., Casolo, G., De Santis, M., Quarta, G., Nistri, S., Cecchi, F., Salton, C. J., Udelson, J. E., Manning, W. J., Maron, B. J. (2008). Assessment and Significance of Left Ventricular Mass by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy. J Am Coll Cardiol 52: 559-566 [Abstract] [Full Text]  
• Weidemann, F., Niemann, M., Herrmann, S., Kung, M., Stork, S., Waller, C., Beer, M., Breunig, F., Wanner, C., Voelker, W., Ertl, G., Bijnens, B., Strotmann, J. M. (2007). A new echocardiographic approach for the detection of non-ischaemic fibrosis in hypertrophic myocardium. Eur Heart J 28: 3020-3026 [Abstract] [Full Text]  
• Hansen, M. W., Merchant, N. (2007). MRI of Hypertrophic Cardiomyopathy: Part I, MRI Appearances. Am. J. Roentgenol. 189: 1335-1343 [Abstract] [Full Text]  
• Hansen, M. W., Merchant, N. (2007). MRI of Hypertrophic Cardiomyopathy: Part 2, Differential Diagnosis, Risk Stratification, and Posttreatment MRI Appearances. Am. J. Roentgenol. 189: 1344-1352 [Abstract] [Full Text]  
• Sechtem, U, Mahrholdt, H, Vogelsberg, H (2007). Cardiac magnetic resonance in myocardial disease. Heart 93: 1520-1527 [Abstract] [Full Text]  
• Assomull, R. G, Pennell, D. J, Prasad, S. K (2007). Cardiovascular magnetic resonance in the evaluation of heart failure. Heart 93: 985-992 [Full Text]  
• Petersen, S. E., Jerosch-Herold, M., Hudsmith, L. E., Robson, M. D., Francis, J. M., Doll, H. A., Selvanayagam, J. B., Neubauer, S., Watkins, H. (2007). Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging. Circulation 115: 2418-2425 [Abstract] [Full Text]  
• Germans, T., Wilde, A. A.M., Dijkmans, P. A., Chai, W., Kamp, O., Pinto, Y. M., van Rossum, A. C. (2006). Structural Abnormalities of the Inferoseptal Left Ventricular Wall Detected by Cardiac Magnetic Resonance Imaging in Carriers of Hypertrophic Cardiomyopathy Mutations. J Am Coll Cardiol 48: 2518-2523 [Abstract] [Full Text]  
• Sipola, P., Peuhkurinen, K, Lauerma, K, Husso, M, Jaaskelainen, P, Laakso, M, Aronen, H J, Risteli, J, Kuusisto, J (2006). Myocardial late gadolinium enhancement is associated with raised serum amino-terminal propeptide of type III collagen concentrations in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the {alpha} tropomyosin gene: magnetic resonance imaging study.. Heart 92: 1321-1322 [Full Text]